379 related articles for article (PubMed ID: 10520975)
21. An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy.
Hirose S; Ashby CR
J Clin Psychiatry; 2002 Aug; 63(8):733-6. PubMed ID: 12197455
[TBL] [Abstract][Full Text] [Related]
22. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
[TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
Costa e Silva J
J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
Stahl SM; Entsuah R; Rudolph RL
Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062
[TBL] [Abstract][Full Text] [Related]
25. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
Barbosa L; Berk M; Vorster M
J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240
[TBL] [Abstract][Full Text] [Related]
26. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
[TBL] [Abstract][Full Text] [Related]
27. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
Bennie EH; Mullin JM; Martindale JJ
J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
[TBL] [Abstract][Full Text] [Related]
28. Venlafaxine in the treatment of postpartum depression.
Cohen LS; Viguera AC; Bouffard SM; Nonacs RM; Morabito C; Collins MH; Ablon JS
J Clin Psychiatry; 2001 Aug; 62(8):592-6. PubMed ID: 11561929
[TBL] [Abstract][Full Text] [Related]
29. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
McIntyre A; Gendron A; McIntyre A
Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
[TBL] [Abstract][Full Text] [Related]
30. A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder.
Westenberg HG; Stein DJ; Yang H; Li D; Barbato LM
J Clin Psychopharmacol; 2004 Feb; 24(1):49-55. PubMed ID: 14709947
[TBL] [Abstract][Full Text] [Related]
31. Residual symptoms in depressed patients who respond acutely to fluoxetine.
Nierenberg AA; Keefe BR; Leslie VC; Alpert JE; Pava JA; Worthington JJ; Rosenbaum JF; Fava M
J Clin Psychiatry; 1999 Apr; 60(4):221-5. PubMed ID: 10221281
[TBL] [Abstract][Full Text] [Related]
32. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
Perugi G; Frare F; Toni C; Ruffolo G; Torti C
Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH
J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
[TBL] [Abstract][Full Text] [Related]
34. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
35. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
[TBL] [Abstract][Full Text] [Related]
36. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
Feighner JP; Overø K
J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
[TBL] [Abstract][Full Text] [Related]
37. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
38. A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
Rapaport M; Coccaro E; Sheline Y; Perse T; Holland P; Fabre L; Bradford D
J Clin Psychopharmacol; 1996 Oct; 16(5):373-8. PubMed ID: 8889909
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.
Feighner JP; Entsuah AR; McPherson MK
J Affect Disord; 1998 Jan; 47(1-3):55-62. PubMed ID: 9476744
[TBL] [Abstract][Full Text] [Related]
40. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM
Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]